ATE529108T1 - Zellmigrationsmodulierende verbindungen - Google Patents

Zellmigrationsmodulierende verbindungen

Info

Publication number
ATE529108T1
ATE529108T1 AT06765332T AT06765332T ATE529108T1 AT E529108 T1 ATE529108 T1 AT E529108T1 AT 06765332 T AT06765332 T AT 06765332T AT 06765332 T AT06765332 T AT 06765332T AT E529108 T1 ATE529108 T1 AT E529108T1
Authority
AT
Austria
Prior art keywords
cell migration
modulating compounds
migration modulating
compounds
angiogenesis
Prior art date
Application number
AT06765332T
Other languages
English (en)
Inventor
Ana Schor
Seth Schor
Rodolfo Marquez
David Norman
Original Assignee
Univ Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Dundee filed Critical Univ Dundee
Application granted granted Critical
Publication of ATE529108T1 publication Critical patent/ATE529108T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06765332T 2005-08-24 2006-08-23 Zellmigrationsmodulierende verbindungen ATE529108T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0517292.9A GB0517292D0 (en) 2005-08-24 2005-08-24 Cell migration modulating compounds
PCT/GB2006/003140 WO2007023273A1 (en) 2005-08-24 2006-08-23 Cell migration modulating compounds

Publications (1)

Publication Number Publication Date
ATE529108T1 true ATE529108T1 (de) 2011-11-15

Family

ID=35198306

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06765332T ATE529108T1 (de) 2005-08-24 2006-08-23 Zellmigrationsmodulierende verbindungen

Country Status (6)

Country Link
US (2) US8242108B2 (de)
EP (1) EP1917012B1 (de)
JP (1) JP5205266B2 (de)
AT (1) ATE529108T1 (de)
GB (1) GB0517292D0 (de)
WO (1) WO2007023273A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8518933B2 (en) 2009-04-23 2013-08-27 Abbvie Inc. Modulators of 5-HT receptors and methods of use thereof
US8546377B2 (en) 2009-04-23 2013-10-01 Abbvie Inc. Modulators of 5-HT receptors and methods of use thereof
ES2423668T3 (es) 2009-05-22 2013-09-23 Abbvie Inc. Moduladores de receptores 5-HT y métodos de uso de los mismos
WO2011146089A1 (en) * 2010-05-21 2011-11-24 Abbott Laboratories Modulators of 5-ht receptors and methods of use thereof
DE102018127797B4 (de) * 2018-11-07 2022-08-04 Infineon Technologies Ag Einen siliziumcarbid-körper enthaltende halbleitervorrichtung
GB202402939D0 (en) 2024-02-29 2024-04-17 Univ Of Canterbury Compounds for cell migration

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU648032B2 (en) * 1989-07-13 1994-04-14 Pharmacia & Upjohn Company (1,2N) and (3,2N)-carbocyclic-2-amino tetralin derivatives
ATE236882T1 (de) * 1992-12-21 2003-04-15 Smithkline Beecham Corp Bicyklische fibrinogen antagoniste
US6458784B1 (en) * 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
JP2000516596A (ja) * 1996-07-25 2000-12-12 バイオジェン，インコーポレイテッド 細胞接着インヒビター
US6569402B1 (en) * 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
GB9908662D0 (en) * 1999-04-15 1999-06-09 Smithkline Beecham Plc Novel process for preparing benzodiazepines
FR2827599A1 (fr) * 2001-07-20 2003-01-24 Neuro3D Composes derives de quinoleine et quinoxaline,preparation et utilisations

Also Published As

Publication number Publication date
EP1917012B1 (de) 2011-10-19
WO2007023273A1 (en) 2007-03-01
US20090221561A1 (en) 2009-09-03
JP5205266B2 (ja) 2013-06-05
US20120264746A1 (en) 2012-10-18
US8962615B2 (en) 2015-02-24
US8242108B2 (en) 2012-08-14
JP2009506017A (ja) 2009-02-12
EP1917012A1 (de) 2008-05-07
GB0517292D0 (en) 2005-10-05

Similar Documents

Publication Publication Date Title
EA200970737A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
CY1122522T1 (el) Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
BR0313330A (pt) Piperidina-ftalazonas substituìdas com pirrolidinadiona como inibidores de pde4
DK1866324T3 (da) Phosphoramidatderivater af nukleosidforbindelser til anvendelse i behandlingen af cancer
BRPI0513310A (pt) análogos de tetrapeptìdeo
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
NO20083147L (no) Anti-OX40L-antistoffer og fremgangsmater for anvendelse av disse
GT200600407A (es) Compuestos ppar activos
ATE488232T1 (de) P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
BRPI0518752A2 (pt) 1-alquinil-2-arilàxi-alquil-amidas e uso do mesmo como fungicidas
TW200519089A (en) Biaryl sulfonamides and methods for using same
EA201000550A1 (ru) Производные тиазола
DE602005017753D1 (de) Mittel für die transdermale verabreichung von nikotin
EA200870515A1 (ru) Моноциклические гетероарильные соединения
TW200519100A (en) Biaryl sulfonamides and methods for using same
ATE472529T1 (de) Prolinamidderivate als natriumkanalmodulatoren
ATE483000T1 (de) Naphtalin-amidin-imide
SE0301650D0 (sv) Novel compounds
BRPI0513149A (pt) uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
EA200600404A1 (ru) Пероральные препаративные формы кладрибина
DE502007005301D1 (de) Verbindungen enthaltend organofluorochlorophosphatanionen
EA200901179A1 (ru) Замещённые тетрагидрохинолины

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties